Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis
Meiling Jin(Northeast Normal University), Meng Yan(Novartis (Switzerland)), William J. Calhoun(Cleveland Clinic), J.S. Elborn(Royal Brompton Hospital), John Aubrey Douglass(The Alfred Hospital), Xavier Jaumont(Novartis (Switzerland)), Ritesh Agarwal(Albert Einstein College of Medicine), Slawomir Lazarewicz(Novartis (Switzerland))
The Journal of Allergy and Clinical Immunology In Practice
December 26, 2022
Cited by 58
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
|Clinical & Experimental Allergy|2013|895